FDA Issues Third Rejection for Aldeyra’s Reproxalap in Dry Eye Disease

March 18, 2026

Life Sciences Voice Top Five Newsletter

August 30, 2023

Carvykti, Johnson & Johnson’s multiple myeloma treatment gains U.S. FDA approval

March 4, 2022

Must Read

Novo Pens Deal With Cellular Intelligence to Advance Parkinson’s Cell Therapy

May 14, 2026

Partner Therapeutics’ Bizengri Grabs FDA Green Light

May 14, 2026

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

May 14, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

CellCentric Raises $220 Million Series D to Advance Inobrodib and Launch Phase 3 Myeloma Trial

Entrada Therapeutics Reports 2.36% Dystrophin Increase in Early DMD Trial Data

Novo Pens Deal With Cellular Intelligence to Advance Parkinson’s Cell Therapy

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Can AI Reduce Drug Development Costs Without Increasing Risk?

Top 10 Skills Every Life Sciences Professional Needs in 2026

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

Commercial

CVC Capital to pay $925 Million to Mallinckrodt for sale of Therakos Business Unit

Editor Picks

FDA Issues Third Rejection for Aldeyra’s Reproxalap in Dry Eye Disease

Life Sciences Voice Top Five Newsletter

Carvykti, Johnson & Johnson’s multiple myeloma treatment gains U.S. FDA approval

Must Read

Novo Pens Deal With Cellular Intelligence to Advance Parkinson’s Cell Therapy

Partner Therapeutics’ Bizengri Grabs FDA Green Light

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

Hot Topics

About Us

Follow Us